Boston Scientific is a global medical technology company that specializes in the development, manufacturing, and marketing of a wide range of medical devices and solutions. The company focuses on providing innovative therapies for various medical conditions, including those affecting the cardiovascular, urology, and gastrointestinal systems, among others. Boston Scientific is committed to advancing patient care through its pioneering technologies, which are designed to improve outcomes and enhance the quality of life for patients around the world. Their product offerings include devices for minimally invasive procedures, enabling healthcare professionals to deliver high-quality care efficiently and effectively. Read More
Boston Scientific Corp (NYSE:BSX) combines strong earnings momentum, expanding margins, and a bullish technical setup, making it a candidate for high-growth investors.
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital.
The select few that can do all three for many years are often the ones that make you life-changing money.
The company said in a regulatory filing that the decision was made in light of increased clinical and regulatory requirements to maintain regulatory approvals in global markets and to obtain approvals in new regions.
Boston Scientific Corp (NYSE:BSX) shows strong growth fundamentals and a bullish technical setup, making it a compelling candidate for growth investors.
Let’s dig into the relative performance of Boston Scientific (NYSE:BSX) and its peers as we unravel the now-completed Q1 medical devices & supplies - diversified earnings season.
BOSTON SCIENTIFIC CORP (NYSE:BSX) meets Minervini’s Trend Template with strong technicals and high growth fundamentals, making it a candidate for momentum investors.
BOSTON SCIENTIFIC CORP (NYSE:BSX) shows strong technicals and a high-quality setup, making it a breakout candidate. The stock has outperformed peers and exhibits bullish patterns with clear support and resistance levels.
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence.
With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability.
But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
See these three stocks that beat on earnings in Q1 and raised their guidance for the rest of 2025. These stocks are signaling strength amid tough conditions.
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
